Priority Date: 21.07.10 (SI 20100000215)

PHARMACEUTICAL ORAL DOSAGE FORMS COMPRISING LERCANIDIPINE AND ENALAPRIL AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS

  • Application ID: EP11727178
  • Status: The patent has been granted

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 11 - 50 employees
Company dna uexkull and stolberg
operating since 1958
Headquarter in Hamburg and 1 office
active in Legal Services

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 21.07.2010 - Priority Date (SI 20100000215)
  • 29.12.2011 - Publication A2 (WO2011161223)
  • 01.05.2013 - Publication A2 (EP2585051)
  • 31.05.2017 - Publication B1 (EP2585051)

IPC Classification